News > Covid vaccine sales push Moderna to $12-bn profit in 2021
Covid vaccine sales push Moderna to $12-bn profit in 2021
Business Standard | 24/02/2022 08:10 PM | Click to read full article
The vaccine maker's COVID-19 shots, which are now available in more than 70 countries, totalled USD 17.7 billion in sales last year, their first full year on the market.
But the company is still waiting for U.S. regulators to authorise the vaccine's use in 12- to 17-year olds, even though several other countries have authorised that expanded use.
